Mattia De Agostini

Dr. Mattia De Agostini

Policlinico di Modena, Modena, Emilia-Romagna, Italy
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Psychiatry Research
Verified
Journal Article
Open access
Marco ColizziMarco Colizzi
Marco Colizzi
NBNatoy Burnett
Natoy Burnett
RCRosalia Costa
Rosalia Costa
MAMattia De Agostini
Mattia De Agostini
JGJames Griffin
James Griffin
SBSagnik Bhattacharyya
Sagnik Bhattacharyya
Cannabis is the most commonly used illicit drug in psychosis patients and has been identified as a risk factor for relapse and subsequent hospital readmission, having substantial economic implications. To clarify the contribution of cannabis consumption to hospital readmission, a consecutive inpatient cohort of 161 early psychosis patients was included into the study. Data on cannabis use at admission and number of hospital readmissions and length of stay (LOS, number of inpatient days) in a 6-year follow-up was extracted from clinical notes. 62.4% of the patients had lifetime cannabis use. Their admission lasted on average 54.3 ± 75 days and over the following 6 years patients had 2.2 ± 2.8 hospital readmissions, for a total of 197.4 ± 331.5 days. Cannabis use significantly predicted the number of hospital readmissions and LOS in the following 6 years, the latter remaining significant after adjusting for use of other substance. Cannabis-using patients of male gender and Black ethnicity had a longer LOS at follow-up compared to female patients and other ethnic groups, respectively. Having a history of cannabis use when admitted to an early intervention inpatient unit for psychosis is associated with a higher number of subsequent hospital readmissions and a longer LOS, especially in male and Black patients.

26 August 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
ABAlessandra Boncompagni
Alessandra Boncompagni
MAMattia De Agostini
Mattia De Agostini
LLLicia Lugli
Licia Lugli
GTGiliana Ternelli
Giliana Ternelli
VCValeria Colonna
Valeria Colonna
ABAlberto Berardi
Alberto Berardi
Mother-to-newborn COVID-19 transmission is mainly postnatal, but single-case reports and small case series have also described SARS-CoV-2 transplacental transmission. Unfortunately, studies regarding vertical transmission of SARS-CoV-2 lack systematic approaches to diagnosis and classification. So far, scientific evidence seems to suggest that the severity of maternal infection increases the risk of vertical transmission. We report two neonates born from COVID-19-positive mothers, of which one of the newborns had a vertical infection. The placental involvement, and consequent intrauterine transmission of SARS-CoV-2, were inversely related to the severity of the maternal disease. The description of cases divergent from current evidence on this topic could provide new insights to better understand SARS-CoV-2 vertical transmission.